These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36707819)

  • 1. Lipid biomarkers that reflect postoperative recurrence risk in lung cancer patients who smoke: a case-control study.
    Takanashi Y; Kahyo T; Hayakawa T; Sekihara K; Kawase A; Kondo M; Kitamoto T; Takahashi Y; Sato T; Sugimura H; Shiiya N; Setou M; Funai K
    Lipids Health Dis; 2023 Jan; 22(1):15. PubMed ID: 36707819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased sphingomyelin (t34:1) is a candidate predictor for lung squamous cell carcinoma recurrence after radical surgery: a case-control study.
    Takanashi Y; Funai K; Eto F; Mizuno K; Kawase A; Tao H; Kitamoto T; Takahashi Y; Sugimura H; Setou M; Kahyo T; Shiiya N
    BMC Cancer; 2021 Nov; 21(1):1232. PubMed ID: 34789180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung adenocarcinoma and squamous cell carcinoma difficult for immunohistochemical diagnosis can be distinguished by lipid profile.
    Yamashita T; Takanashi Y; Uebayashi A; Oka M; Mizuno K; Kawase A; Oyama S; Kitamoto T; Kondo M; Omori S; Tao H; Takahashi Y; Sakamoto T; Kahyo T; Sugimura H; Setou M; Shiiya N; Funai K
    Sci Rep; 2023 Jul; 13(1):12092. PubMed ID: 37495609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingomyelin(d35:1) as a novel predictor for lung adenocarcinoma recurrence after a radical surgery: a case-control study.
    Takanashi Y; Funai K; Sato S; Kawase A; Tao H; Takahashi Y; Sugimura H; Setou M; Kahyo T; Shiiya N
    BMC Cancer; 2020 Aug; 20(1):800. PubMed ID: 32831036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical impact of family history of cancer in female never-smoker lung adenocarcinoma.
    Lee Y; Jeon JH; Goh SH; Roh H; Yun JY; Kwon NJ; Choi JH; Yang HC; Kim MS; Lee JM; Lee GK; Han JY
    Lung Cancer; 2019 Oct; 136():15-22. PubMed ID: 31421257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
    Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
    Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
    Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cigarette smoking on metabolic activity of lung cancer on baseline
    Jiang M; Guo X; Zhang X; Gao Q; Mei W; Zhang J; Zheng J
    PeerJ; 2022; 10():e13352. PubMed ID: 35497180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Lung Adenocarcinoma by Age, Sex, and Smoking Status in Taiwan.
    Chien LH; Jiang HF; Tsai FY; Chang HY; Freedman ND; Rothman N; Lan Q; Hsiung CA; Chang IS
    JAMA Netw Open; 2023 Nov; 6(11):e2340704. PubMed ID: 37910104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined double CK5/P63 stain: useful adjunct test for diagnosing pulmonary squamous cell carcinoma.
    Fatima N; Cohen C; Lawson D; Siddiqui MT
    Diagn Cytopathol; 2012 Nov; 40(11):943-8. PubMed ID: 21472873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.
    Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M
    BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.
    Mandarano M; Orecchini E; Bellezza G; Vannucci J; Ludovini V; Baglivo S; Tofanetti FR; Chiari R; Loreti E; Puma F; Sidoni A; Belladonna ML
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key.
    Kaur H; Sehgal IS; Bal A; Gupta N; Behera D; Das A; Singh N
    Indian J Cancer; 2017; 54(1):285-290. PubMed ID: 29199707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Lipidomics for Assessing Tissue Lipid Profiles of Patients With Squamous Cell Carcinoma.
    Zeng W; Zheng W; Hu S; Zhang J; Zhang W; Xu J; Yu D; Peng J; Zhang L; Gong M; Wei Y
    Technol Cancer Res Treat; 2021; 20():15330338211049903. PubMed ID: 34761720
    [No Abstract]   [Full Text] [Related]  

  • 15. The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients.
    Wang BY; Huang JY; Chen HC; Lin CH; Lin SH; Hung WH; Cheng YF
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):43-52. PubMed ID: 31705294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Survivin Protein Levels in Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
    Puskas R; Bikov A; Horvath P; Lazar Z; Kunos L; Nagy R; Pinter G; Galffy G
    Pathol Oncol Res; 2021; 27():631969. PubMed ID: 34257598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and targeted therapy in non-small cell lung cancer.
    Chen Y; Liu Q; Chen Z; Wang Y; Yang W; Hu Y; Han W; Zeng H; Ma H; Dai J; Zhang H
    J Exp Clin Cancer Res; 2019 May; 38(1):193. PubMed ID: 31088500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matched-pair analysis of a multi-institutional cohort reveals that epidermal growth factor receptor mutation is not a risk factor for postoperative recurrence of lung adenocarcinoma.
    Matsumura Y; Suzuki H; Ohira T; Shiono S; Abe J; Sagawa M; Sakurada A; Katahira M; Machida Y; Takahashi S; Okada Y
    Lung Cancer; 2017 Dec; 114():23-30. PubMed ID: 29173761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.
    Haga Y; Hiroshima K; Iyoda A; Shibuya K; Shimamura F; Iizasa T; Fujisawa T; Ohwada H
    Ann Thorac Surg; 2003 Jun; 75(6):1727-32; discussion 1732-3. PubMed ID: 12822607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.